Welcome to LookChem.com Sign In|Join Free

CAS

  • or

27473-03-6

Post Buying Request

27473-03-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27473-03-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 27473-03-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,4,7 and 3 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 27473-03:
(7*2)+(6*7)+(5*4)+(4*7)+(3*3)+(2*0)+(1*3)=116
116 % 10 = 6
So 27473-03-6 is a valid CAS Registry Number.

27473-03-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethanol

1.2 Other means of identification

Product number -
Other names 2-(p-Chlorphenyl)-4-hydroxyethylthiazol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27473-03-6 SDS

27473-03-6Relevant articles and documents

PROCESS FOR PREPARING A POTENT THIAZOLE COMPOUND, PHARMACEUTICAL FORMULATION AND USES THEREOF

-

, (2019/11/12)

The present invention relates to a process for preparing N-[2-[2-(4-chlorophenyl)-4- thiazolyl] ethyl]-butanamide. The present invention further relates to a pharmaceutical formulation and the use of said pharmaceutical formulation consisting of N-[2-[2-(

THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS

-

Page/Page column 39, (2008/06/13)

The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein w, R1, q, p, R2, t, Ar1, L1, R3 and R4 are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.

Metabolism of 2-(4-chlorophenyl)thiazol-4-ylacetic acid (fenclozic acid) and related compounds by microorganisms.

Howe,Moore,Rao,Wood

, p. 1040 - 1045 (2007/10/05)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27473-03-6